Products
Treprostinil is commercially available as an infusion solution (Remodulin, generic). It has been approved in many countries since 2004.
Structure and properties
Treprostinil (C23H34O5, Mr = 390.5 g/mol) is a synthetic prostacyclin.
Effects
Treprostinil (ATC B01AC21) has vasodilator and antiplatelet properties.
Indications
- Primary pulmonary hypertension
- Pulmonary arterial hypertension
